Antihypertensive effect of some oxazolo[3,2-a]pyridines, thiazolo[3,2-a]pyridines and pyrido[2,1-b]oxazines in conscious spontaneously hypertensive rats

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 4, 1997, Pages 421-425

  Moran, Asunción ^a   Martín, Elena ^a   Velasco, Cristina ^a   Martín, M Luisa ^a   San Roman, Luis ^a   Caballero, Esther ^a   Puebla, Pilar ^a   Medarde, Manuel ^a   San Feleciano, Arthuro ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NIFEDIPINE; OXAZINE DERIVATIVE; OXAZOLO[3,2 A]THIENO[3,2 D]PYRIMIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SYNTHESIS; HYPERTENSION; HYPOTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION; TACHYCARDIA;

EID: 0030916533     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06817.x     Document Type: Article

References (21)

1. Caballero, E., Puebla, P., Medarde, M., San Feliciano, A. (1993) Regiochemistry in the synthesis of 2,3,8,8a-tetrahydro-7H-oxazolo[3,2-a]pyridines. Tetrahedron 49: 10079-10088
2. Caballero, E., Puebla, P., Medarde, M., Sánchez, M., Salvadó, M. A., García-Granda, S., San Feliciano, A. (1996) Synthesis of enantiopure 2,3,8,8a-tetrahydro-7H-oxazolo[3,2-a]pyridine derivatives. J. Org. Chem. 61: 1890-1893
3. Cauvin, C., Loutzenhiser, R., Vanbreemen, C. (1983) Mechanism of calcium antagonist-induced vasodilation. Ann. Rev. Pharmacol. Toxicol. 23: 373-396
4. Follath, F., Taeschner, W. (1988) Clinical pharmacology of calcium antagonists. J. Cardiovasc. Pharmacol. 12 (Suppl. 6): S98-S100
5. Freis, E. D. (1960) Haemodynamics of hypertension. Physiol. Rev. 40: 27-54
6. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee (1993) Guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension Meeting. Hypertension 22: 392-403
7. Julius, S. (1988) Amlodipine in hypertension: an overview of the clinical dossier. J. Cardiovasc. Pharmacol. 12 (Suppl. 7): S27-S33
8. Kanda, A., Haruno, A., Miyake, H., Nagasaka, M. (1992) Antihypertensive effects of MPC-1304, a novel calcium antagonist in experi-ental hypertensive rats and dogs. J. Cardiovasc. Pharmacol. 20: 723-730
9. Klaus, D. (1992) The role of calcium antagonists in the treatment of hypertension. J. Cardiovasc. Pharmacol. 20 (Suppl. 6): S5-S14
10. Mulvany, M. J., Nyborg, N. (1982) An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive rats. Br. J. Pharmacol. 71: 585-596
11. Ohtsuka, M., Yokota, M., Kodama, I., Yamada, K., Shibata, S. (1989) New generation dihydropyridine calcium entry blockers: in search of greater selectivity for one tissue subtype. Gen. Pharmacol. 20: 539-556
12. Rafterty, E. B., Heber, M. E., Brigden, G., Al-Khawaja, I. (1991) 24-Hour blood pressure control with the once-daily calcium antagonist amlodipine. J. Cardiovasc. Pharmacol. 17 (Suppl. 1): S8-S12
13. San Feliciano, A., Caballero, E., Pereira, J. A. P., Puebla, P. (1991) 2,3,8,8a-tetrahydro-7H-oxazolo[3,2-a]pyridine: a new heterocyclic system. Tetrahedron 47: 6503-6510
14. San Feliciano, A., Caballero, E., Puebla, P., Pereira, J. A. P., Gras, J., Valenti, C. (1992) Synthesis and pharmacological activities of some pyrido[2,1-b]oxazines. Eur. J. Med. Chem. 27: 527-535
15. Sorkim, E. M., Clissold, S. P., Brodgen, R. N. (1985) Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in ischemic heart disease, hypertension and related disorders. Drugs 30: 182-274
16. Stumpe, K. O. (1992) Antihypertensive therapy: new strategies beyond blood pressure control. J. Cardiovasc. Pharmacol. 20 (Suppl. 6): S1-S4
17. Sugiyama, T., Yoshizumi, M., Tkaku, F., Yazaki, Y. (1990) Abnormal calcium handling in vascular smooth muscle cells in spontaneously hypertensive rats. J. Hypertens. 8: 369-375
18. Taira, N. (1987) Differences in cardiovascular profile among calcium antagonists. Am. J. Cardiol. 59: 24b-29b
19. Takada, T., Miyawaki, N., Kageyama, M., Matsuno, K., Ishida, N., Yamauchi, H., Iso, T. (1991) Antihypertensive effect of a novel calcium antagonist, SD-3211, in experimental hypertensive rats. J. Cardiovasc. Pharmacol. 18: 855-862
20. Tallarida, R. J., Murray, R. B. (1984) Manual of Pharmacological Calculations with Computer Programs. Springer, New York
21. Unidipin Co-operative Study Group (1992) New sustained-release nifedipine formulation in treatment of essential hypertension. J. Cardiovasc. Pharmacol. 19: 349-353